Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Same to you! A big thanks for any and all veterans.
I have been hearing If this If that for years. You will soon come around to the reality of the situation soon enough.
The only "if" is if the CEO continues non-arms length transactions how long will he continue to last?
Haha! Buy all under 0.35!! Forget to mention that it will be closer to 0.02 than 0.97 for a loooong time.
Results are results. The company has potential, but I think management has done a terrible job the last 12 months.
We may have to wait for an update after next Valentine's Day dinner just to realize that he's been stood up.
He did before and the dialogue has since changed. He preciously said that the company could get to NASDAQ on the fundamentals alone. That was before the CRL, of course, and prior to the incessant dilution.
"We will see what happens" sounds like the usual solid plan.
These are never scheduled. Always an option on the table.
Good thing expectations were met and nailed down that hard shell Oxy ANDA "this" quarter.
If anything, this company is consistent.
Could simply be turnover.
Article: https://news.google.com/news/amp?caurl=http%3A%2F%2Fwww.cnn.com%2F2017%2F06%2F29%2Fhealth%2Fohio-overdose-proposal-trnd%2Findex.html#pt0-25903
Extremely sad of what the opiate situation is coming down to - raise taxes to support the medical assistance & crisis situation or simply stop sending help. Wow.
No BK is coming, but there will be plenty more dilution to cover all the excuses.
First he wants to validate they even really work so he is forcing additional studies.
Won't need to since it is posted multiple times each day.
Haha! Funny that an entire site is shut down to post an entry-level position.
Nasrat just forgot to insert the word "next" as in this next quarter.
Was that before or after dumping of shares?
That was one day. And what has it done since? Very sad.
How has the price increased since the cc? I see quite the opposite, as usual.
...Plus J shares
I will quote Nasrat from the last cc, "that was really disappointing."
I guess so. Sort of like an inverted ladder after the fall from 0.97.
Actually looks like lots of selling has taken place since the last conference call again. With self-dealing CEO is getting a payday regardless of stock price.
How have they been doing sequentially recently? Not climbing for sure.
Haha! It was one of the reasons. Didn't I hear Methadone contracted sales dropped significantly during the quarter? Good thing they didn't use the excuse of "shipping delays". Would have been the 3rd straight quarter.
How is that July 2016 slam dunk approval doing?
If it is a 5-bagged that assumes only a 20% annual growth rate. That would be a piss poor return for the risk involved here and I would be embarrassed if I was in management if that really was the outcome.
It is only about the IMS data.
"Continue to climb". That is exactly what has been happening since the conference call...as usual.
Exactly
I am focusing on known pipeline that is the near-term focus for this company in billion dollar IMS markets with lots of competitors, some with ADF products, some with generics and all with branded.
We know very little about SunGen opportunities and give them little credence at this point. Elite still has to prove to the FDA that their technology works favorably. Lots of barking, but little bites so far.
The proof will be in the pudding soon enough.
To say the branded drugs and generics aren't competition is ignoring the basic market dynamics. Completely foolish.
IMS data means little when the field is already flooded with competitors. I find it funny how this is always ignored by "investors".
I find it hysterically funny that we all "know" it is going to trade at $1. Basics of supply and demand tell us otherwise. If we all knew that the stock would fill that gap up to the discounted value of today.
Not sure I see that today, but I do see lots of selling pressure.
There may be some truth to that. Extreme confidence to stabilize stock (never happened after cc though) to allow further and further dilution.
I don't think the trading is a signal of the results. I was only implying the tone in which Nasrat used didn't signal confidence in favorable results.
Wow. Only missed by 5 years so far. About as accurate as all the other forecasts as well.
How is Epic's Oxy game changer faring again? Probably going to be outdone by Trimipramine.
Again, not in this most recent call. No dollar amount was stated because of all the additional dilution. Can't get to a buck now without an R/S.
That was my opinion as stated. Saying defined thresholds as stated by CEO is not a fact, but a pure lie.
He said nothing about any dollar threshold. That is a completely made up statement not based on any fact.
They already are saving billions. Elite is late to the game in Canada.